Patients affected by PSP and distribution of PSPs by treatment areas
| Treatment areas | Patients | PSPs | ||||
| n* | % | 95% CI | n | % | 95% CI | |
| Anamnesis/diagnostic procedures | 938 | 66.0 | 63.5 to 68.4 | 1583 | 61.1 | 59.3 to 63 |
| Medication | 316 | 22.3 | 20.1 to 24.4 | 398 | 15.4 | 14 to 16.8 |
| Vaccination, injection, infusion | 100 | 7.0 | 5.8 to 8.4 | 112 | 4.3 | 3.6 to 5.2 |
| Aftercare | 53 | 3.7 | 2.8 to 4.8 | 65 | 2.5 | 2 to 3.2 |
| Outpatient surgery | 41 | 2.9 | 2.1 to 3.9 | 61 | 2.4 | 1.8 to 3 |
| Office administration | 208 | 14.6 | 12.9 to 16.5 | 254 | 9.8 | 8.7 to 11 |
| Other areas | 116 | 8.1 | 6.8 to 9.7 | 116 | 4.5 | 3.7 to 5.3 |
| Sum | 1422† | 2589 | 100.0 | |||
*Multiple answers possible; sample: 8776 weighted patients ≥40 years with a doctor's visit within the last 12 months.
†Individual patients, some affected by several PSPs.
PSP, patient safety problem.